Argitalpenak (27) Ikertzaileren baten partaidetza izan duten argitalpenak

2002

  1. Extraction and LC determination of lysine clonixinate salt in water/oil microemulsions

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 27, Núm. 5, pp. 747-754

2001

  1. Absorción transbucal de fármacos

    Ciencia y Tecnologia Pharmaceutica, Vol. 11, Núm. 2, pp. 65-74

  2. First-derivative spectrophotometric and LC determination of nifedipine in Brij® 96 based oil/water/oil multiple microemulsions on stability studies

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 26, Núm. 4, pp. 563-572

  3. In vitro release of metociopramide from hydrophobic matrix tablets. Influence of hydrodynamic conditions on kinetic release parameters

    Chemical and Pharmaceutical Bulletin, Vol. 49, Núm. 10, pp. 1267-1271

  4. Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables

    Drug Development and Industrial Pharmacy, Vol. 27, Núm. 8, pp. 847-855

1999

  1. Comparison of derivative spectrophotometric and liquid chromatograpic methods for the determination of omeprazole in aqueous solutions during stability studies

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 21, Núm. 2, pp. 291-298

  2. Preparation and characterization of albendazole β-cyclodextrin complexes

    Drug Development and Industrial Pharmacy, Vol. 25, Núm. 12, pp. 1241-1248

1997

  1. Polyamide-6,10 microcapsules: Effect of organic phase

    Proceedings of the Controlled Release Society

1996

  1. Application of differential scanning calorimetry and X-ray powder diffraction to the solid-state study of metoclopramide

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 15, Núm. 1, pp. 131-138

1995

  1. An experimental design applied to the statistical analysis of inert matrices dissolution data

    Drug Development and Industrial Pharmacy, Vol. 21, Núm. 20, pp. 2287-2306

  2. Gelatinized/freeze-dried starch as excipient in sustained release tablets

    International Journal of Pharmaceutics, Vol. 115, Núm. 2, pp. 201-208

  3. MATRICES INERTES COMO FORMAS DE LIBERACION CONTROLADA DE MEDICAMENTOS ADMINISTRADOS POR VIA ORAL

    Ciencia Pharmaceutica, Vol. 5, Núm. 6, pp. 249-258

1994

  1. Latin square in matrices dissolution testing

    Proceedings of the Controlled Release Society

  2. Matrix tablets containing HPMC and polyamide 12: Comparison of dissolution data using the gompertz function

    Drug Development and Industrial Pharmacy, Vol. 20, Núm. 16, pp. 2509-2518

1992

  1. In vitro study of mixed controlled release matrix tablets containing HMPC and polyamide 12

    Drug Development and Industrial Pharmacy, Vol. 18, Núm. 20, pp. 2163-2171

1991

  1. Controlled release tablets prepared with a bioadhesive polymer

    S.T.P. Pharma Sciences, Vol. 1, Núm. 5, pp. 313-317